دورية أكاديمية

Hemangiopoietin supports animal survival and accelerates hematopoietic recovery of chemotherapy-suppressed mice.

التفاصيل البيبلوغرافية
العنوان: Hemangiopoietin supports animal survival and accelerates hematopoietic recovery of chemotherapy-suppressed mice.
المؤلفون: Zi Liang Xu, Bin Zhou, Xiu Li Cong, Liu, Yong Jun, Bin Xu, Yan Han Li, Jie Gu, Zhong Chao Han
المصدر: European Journal of Haematology; Dec2007, Vol. 79 Issue 6, p477-485, 9p, 5 Graphs
مصطلحات موضوعية: CELLULAR immunity, GROWTH factors, CELL lines, ANIMAL models in research, DRUG therapy, BONE marrow
مستخلص: Objective: To determine if recombinant human hemangiopoietin (HAPO), a novel growth factor for primitive cells of hematopoietic and endothelial cell lineages, accelerates hematopoietic reconstitution after high-dose chemotherapy in vivo in mice. Methods: Male Balb/c mice after treatment of 5-flourouracil were subcutaneously injected with HAPO or its dilution for consecutive 10 d. Their survival and body weight together with peripheral blood were routinely tested. At day 7 and 14, the numbers of bone marrow (BM) cells as well as colony-forming units (CFU) after in vitro colony culture were counted. The peripheral blood CFU and the percentage of CD34+CD117+ cells in BM were analyzed. Transwell chamber was used for cell migratory assay. Results: HAPO at different doses significantly increased the survival rate and body weight, with an optimal effect in the HAPO 10 μg/d group. The number of BM cells and the percentage of CD34+CD117+ cells were also increased after HAPO administration. The number of granulocyte/macrophage CFU and granulocyte, erythroid, macrophage and megakaryocyte CFU in BM after HAPO treatment was greater than that from the HAPO dilution group. More circulating CFU could be observed after injection of HAPO. In addition, this novel cytokine had a chemotactic effect on the hematopoietic stem/progenitor cells. Conclusion: HAPO improves animal survival and accelerates hematopoietic reconstitution of mice after high-dose chemotherapy. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Haematology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:09024441
DOI:10.1111/j.1600-0609.2007.00969.x